Introduction
Protein kinase CK2 (formerly casein kinase II) is a multifunctional protein kinase that has crucial roles in cell differentiation, proliferation and survival (Ahmed et al., 2002; Litchfield, 2003) . The enzyme is described as a multi-subunit protein kinase that is generated by the association of two catalytic subunits a or a 0 with a dimer of b regulatory subunits leading to the idea that CK2 functions as a stable heterotetrameric complex. However, this traditional view has been challenged by the evidence for naturally occurring free monomeric CK2a (Dobrowolska et al., 1992; Stigare et al., 1993; Heriche et al., 1997) and for an unbalanced expression of CK2 subunits in different mammalian tissues (Stalter et al., 1994; Pinna and Meggio, 1997; Guerra et al., 1999b; Ghavidel and Schultz, 2001; Keller et al., 2001) . Moreover, the marked elevation of CK2 enzymatic activity in various solid tumors is suspected to result in the suppression of cellular apoptosis, aiding tumor resistance to radiation and anticancer drug treatments (Guerra and Issinger, 1999; Ahmed et al., 2002) .
The CK2b subunit exhibits several regulatory functions related to the stability, the activity and the specificity of CK2a and CK2a 0 in the holoenzyme complex (Guerra et al., 1999a) . The three-dimensional structure of the CK2b dimer has revealed the presence of solvent-exposed and -conserved residues that may represent binding surfaces for the multiple protein ligands previously identified as CK2b partners (Chantalat et al., 1999; Grein et al., 1999; Filhol et al., 2004) . The identification of important protein kinases including A-Raf, c-Mos, Chk1 and Chk2 (Guerra et al., 1999b (Guerra et al., , 2003 Bjorling-Poulsen et al., 2005) that interact with CK2b in the absence of catalytic CK2 subunits strongly suggests that CK2b has functions distinct from CK2a (Bibby and Litchfield, 2005) . Moreover, live-cell fluorescent imaging and X-ray crystallography studies (Niefind et al., 2001) have revealed the subcellular dynamics of CK2 subunits and the transient nature of their interaction. These data again support of the notion that at least some aspects of CK2b functions are not based on its interaction with the CK2 catalytic subunit (Filhol et al., 2004; Bibby and Litchfield, 2005) . In mice as well as in Caenorhabditis elegans, a functional loss of CK2b is lethal, demonstrating that the protein is essential for viability (Fraser et al., 2000; Buchou et al., 2003) . These genetic knockouts also illustrate the dramatic phenotypic consequences of disrupting all the potential interactions in which the CK2b protein is involved. However, one of the intriguing questions regarding this interacting protein is which partners are critically required for cell viability. Therefore, reagents that could block in vivo, specific interactions between CK2b and some of its partners but not others, would help to elucidate the functional significance of this protein in cell survival signalling pathways. The twohybrid screening of combinatorial libraries of peptide aptamers is a powerful technique to identify peptides that mimic protein surfaces and interfere with protein interactions inside cells (Colas et al., 1996) . This technology has been successfully used to target important proteins in living cells (Colman-Lerner et al., 2001) . Here, we used this approach to select an aptamer that specifically interacts with CK2b both in vitro and intracellularly. This peptide aptamer and the 19-mer synthetic peptide corresponding to its variable region (peptide P1) bind with high affinity to the N-terminal region of CK2b without disrupting the formation of functional CK2 holoenzyme. However, targeting CK2b with the aptamer-derived synthetic peptide in mammalian cells induces apoptosis through the recruitment of the p53-dependent pathway. Cells expressing the green fluorescent protein (GFP)-P1 peptide showed upregulation of p53 phosphorylated on serine 15, p21 induction, mitochondrial release of proapoptotic effectors such as Cyt-C and apoptosis-inducing factor (AIF), and activation of caspase-3.
These data show that peptide aptamers will be useful molecular tools in studying the organization and function of CK2b and for identifying specific CK2b partners that are crucial for cell survival.
Results

Isolation of CK2b-interacting peptide aptamers
To identify peptide aptamers interacting with the regulatory subunit of the CK2 (CK2b), we used the yeast two-hybrid system. Peptide aptamers were selected from a high complexity library of random 20-mers inserted into the active-site loop of Escherichia coli thioredoxin A (TrxA) protein (Colas et al., 1996) (for details see the Supplementary Information). From 4 Â 10 5 transformants, we isolated two clones that allowed the expression of peptide aptamers interacting with CK2b. These aptamers had STOP codons localized within their variable regions, resulting in the expression of unconstrained peptides P1 and P2 of 19 and 6 amino acids (aa), respectively, fused to the amino-terminal region of TrxA. In the following, we focused on the TrxA-P1 aptamer. The variable region of TrxA-P1 is enriched in hydrophobic amino acids (26% of leucine), and a BLAST analysis of the publicly available databases reveals that its sequence has significant homology to murine cytomegalovirus IE2 protein (Genbank accession number AY037931) (Messerle et al., 1991) (Figure 1a ). Interestingly enough, the cytomegalovirus IE2 protein is known to interact with CK2b, inhibits the cell cycle (Wiebusch and Hagemeier, 2001 ) and triggers cell apoptosis (Chiou et al., 2001) .
Selected peptide aptamer P1 interacts with CK2b in vitro The binding of the isolated peptide aptamer was verified in glutathione-S-transferase (GST) pull-down experiments. Equal amounts of GST alone or GST-aptamer fusion protein (GST-P1) were immobilized on glutathione beads and incubated with a lysate of CK2b-expressing Sf9 cells. Retained CK2b was visualized by Western blotting. Unlike the GST protein lacking the inserted aptamer, GST-P1 is able to interact with cellular CK2b in vitro (Figure 1a) .
To determine whether the unconstrained 19-mer region alone without the amino-terminal region of thioredoxin would display the same properties than the TrxA-P1 fusion protein, a biotinylated 19-mer peptide corresponding to the P1 sequence (biot-P1) was coupled to agarose beads and then incubated with cellular extracts of NIH3T3 or HeLa cells. As shown in Figure 1b , biot-P1 retained a capacity to interact with cellular CK2b in vitro, demonstrating that the unconstrained variable region of the aptamer, which is likely unstructured, is efficient for binding.
Then, we directly assessed the interaction between biot-P1 and CK2b by surface plasmon resonance spectroscopy (BIAcore AB). Biot-P1 was immobilized on CM5 sensorchips and recombinant myelin basic protein (MBP) or MBP-CK2b were flowed as soluble analytes over the chip. The kinetic parameters of the interaction between biot-P1 and MBP-CK2b were determined by recording sensorgrams at different MBP-CK2b concentrations (Figure 1c ). The association (k on ), the dissociation (k off ) rate constants and the resulting average equilibrium dissociation constant (K D ) are summarized in Figure 1c . Under these experimental conditions, a K D value of 0.4 mM was estimated. This is comparable with K D values for other biologically important interactions, including those between various SH2 domains and receptor-mimicking phosphopeptides (K D E0.3-130 mM) (Ladbury et al., 1995; Zhou et al., 1995) .
To determine the minimal region of CK2b that was implicated in the interaction with peptide P1, different sequences of CK2b, aa 1-55, aa 1-150 and aa 182-215 (see the linear representation of CK2b in Figure 1d ), were fused to GST and the binding of the corresponding recombinant proteins to biot-P1 was compared to the interaction between biot-P1 and GST-CK2b by an enzyme-linked immunosorbent assay (ELISA). The histogram presented in Figure 1d shows that the main interacting site for biot-P1 is localized in the N-terminal domain of . Surprisingly, this domain exhibited a better affinity for biot-P1 than the fulllength CK2b. In contrast, the C-terminal part of the CK2b interacted very poorly with the biot-P1 peptide.
Moreover, BIAcore experiments using GST-CK2b 1À55 as the analyte flowed over biot-P1 showed a high-affinity interaction between the N-terminal domain of CK2b and immobilized biot-P1 (data not shown).
Effect of peptide P1 on CK2 activity
In order to assess whether P1 could alter CK2 functions, we first examined the effect of recombinant GST-P1 on the association in vitro between recombinant GFPCK2a and MBP-CK2b (Figure 2a ) or on a preformed complex containing recombinant GFP-CK2a/MBPCK2b (Figure 2b) A CK2b subunit-interacting peptide induces p53-dependent cell apoptosis V Martel et al ( Figure 2a ). Similarly, GST-P1 was unable to dissociate the preformed holoenzyme complex ( Figure 2b ). As CK2b is required to achieve optimal catalytic activity toward most CK2 substrates (Martel et al., 2002) , we have evaluated the effect of P1 on the in vitro phosphorylation of Engrailed and CDC25B, two proteins whose phosphorylation by CK2 is strictly dependent on the presence of CK2b (Maizel et al., 2002; Theis-Febvre et al., 2003) . Figure 2c shows that as expected, these two recombinant proteins are not phosphorylated by CK2a but became highly phosphorylated in the presence of CK2b. However, increasing concentrations of biot-P1 in the assays had apparently no effect on the CK2b-dependent phosphorylation of these proteins. Thus, at least for these two substrates, the binding of P1 to CK2b did not alter the catalytic activity of the CK2 holoenzyme.
P1 colocalizes with CK2b in cultured cells
To assess the biological activities of the CK2b-binding aptamer, peptide P1 in fusion with GFP was expressed in NIH3T3 cells. An expression plasmid encoding an irrelevant 20-mer aptamer fused to TrxA and to GFP (peptide P CT ) was used as a control. As shown in Figure 3a , peptides P CT and P1 were expressed as GFP fusion proteins with the expected apparent molecular weights of 42 and 33 kDa, respectively. A CAAX membrane targeting sequence was added to a BFP or CK2b-BFP constructs to ectopically target the fusion proteins to the cytoplasmic membrane (Martel et al., 2002) . Transient expression of BFP-CAAX alone in GFP-peptide-expressing cells did not change the localization of either GFP-P CT or GFP-P1, which both exhibited a diffused nuclear and cytoplasmic localization ( Figure 3b ). In contrast, expression of BFP-CK2b-CAAX in GFP-P1-expressing cells resulted in a punctuate green fluorescence localized both in nuclear and plasma membranes (Figure 3c ), whereas the distribution of GFP-P CT remained unchanged in BFP-CK2b-CAAX-expressing cells ( Figure 3c ). Altogether, these experiments demonstrate that like in yeast strain, GFP-P1 colocalizes with CK2b in NIH3T3 cells.
Expression of peptide P1 triggers cell apoptosis
To gain insight into the effects of P1 in living cells, we tried to generate NIH3T3 clones stably expressing GFP-P1 fusion protein. However, after few passages, we could not isolate live GFP-P1-expressing cells. Consequently, NIH3T3 cells were transiently transfected with GFP-P1 or GFP-P CT . Cells expressing the GFP-P1 construct, but not GFP-P CT , exhibited characteristic morphological changes associated with apoptosis, including membrane blebbing, cell shrinkage and nuclear fragmentation and died in 2-3 days. The fact that cell viability was not affected by the expression of GFP fused to an irrelevant 20-mer aptamer showed that apoptosis induction depends on the expression of P1 and that the GFP moiety is dispensable. Similarly, transient expression of GFP-P1 in MCF-10A, and HCT116 cells led to a massive cell death (not shown),
indicating that P1 induces a death response in a cell lineindependent manner. Cell cycle analysis of propidium iodide-stained NIH3T3 cells by flow cytometry revealed a massive sub-G1 peak (36.2%) in the GFP-P1-expressing cell population ( Figure 4a ). In contrast, this sub-G1 cell population in GFP-P CT -transfected cells was weak (8.6%). NIH3T3 cells expressing GFP-P1 or GFP-P CT were also stained with Annexin V-Alexa 568 (Figure 4b ). After 48 h of transfection, a few cells in the control (18%) were stained with Annexin V. In contrast, NIH3T3 cells were transiently transfected with plasmids encoding GFP-P CT or GFP-P1 fusion proteins. After 30 h, expression of GFP-P CT and GFP-P1 was analysed by Western blotting with an antibody specific for GFP. An extract from non-transfected cells was used as a control (NT). (b) NIH3T3 cells were co-transfected with GFP-P CT or GFP-P1 vectors and a plasmid encoding the BFP-CAAX fusion protein, which is addressed to the cell membranes. After 24 h, both GFP-P CT and GFP-P1 proteins were diffused in the nucleus and in the cytoplasm of co-transfected cells.
(c) The same GFP constructs were transiently co-transfected under the same conditions, with a plasmid encoding for a BFP-CK2b-CAAX protein. Expression of the BFP-CK2b-CAAX protein had no effect on the GFP-P CT cellular localization, but led to the colocalization into a punctuate pattern of GFP-P1 and BFP-CK2b-CAAX proteins (white arrows).
A CK2b subunit-interacting peptide induces p53-dependent cell apoptosis V Martel et al many cells transfected with GFP-P1 were Annexin V positive (53%). A terminal deoxy transferase uridine triphosphate nick end-labelling (TUNEL) assay showed that only 25% of GFP-P CT -expressing cells were rhodamin positive, whereas GFP-P1-expressing cells exhibited a significantly higher percentage of bright cells (60%) (Figure 4b ). Thus, transient expression of the GFP-P1 induced characteristic biological changes associated with apoptosis.
To demonstrate that GFP-P1-induced cell apoptosis was indeed the result of a specific targeting of CK2b, we analysed apoptosis in CK2b-overexpressing cells. For this, NIH3T3 cells were first transfected with a plasmid encoding for HA-tagged CK2b or with a pSG5 plasmid as a control. After 24 h, cells were transfected again with GFP-P CT or GFP-P1 and fixed 24 h later. Expression of the HA-CK2b protein was checked by immunofluorescence using an anti-HA antibody and the number of GFP-positive cells was counted in each condition. As shown in the histogram presented in Figure 4c , overexpression of CK2b in GFP-P1-expressing cells resulted in a significantly higher percentage of GFP-positive live cells than in control cells (40 vs 20%). This partial protection was in agreement with the transfection efficiency. These observations support the notion that binding of P1 to CK2b is, at least one step, required to initiate a cell death response, and that increasing the number of CK2b molecules, available in cells, can significantly protect cells that would have normally died.
To determine whether P1-induced apoptosis was sensitive to inhibition of CK2 catalytic activity, NIH3T3 cells transfected with GFP-P1 or GFP-P CT were treated with tetrabromobenzotriazole (TBB), a low molecular weight CK2-specific inhibitor. As shown in Figure 1 (Supplementary Information), the percentage of apoptotic GFP-positive cells was significantly decreased by TBB treatment in GFP-P1-expressing cells (55 vs 30%), whereas it was unaffected in control cells. Under these experimental conditions, CK2 activity was inhibited by 92% in TBB-treated cells. It should be noted that this almost complete inhibition of CK2 catalytic activity only led to partial reversion of P1-induced apoptosis. These data suggest the activation of a TBB-resistant pathway in response to GFP-P1 expression.
It was recently suggested that CK2 can exert an antiapoptotic role by protecting regulatory proteins from caspase-mediated degradation (Litchfield, 2003) . Indeed, a caspase-3 activation was detected in GFP-P1-expressing cells when assayed with an activated caspase-3 antibody ( Figure 5 ). In order to determine whether P1-induced apoptosis could arise from a general activation of caspase signalling, we examined the effect of the broad-spectrum caspase inhibitor Z-VAD-fmk (Z-ValAla-DL-Asp (OMe)-fluoromethylketone), on GFP-P1-induced apoptosis. As shown in Figure 4d , overnight treatment of cells with Z-VAD-fmk blocked, by 82%, the staurosporine-induced apoptosis. In contrast, P1-induced cell death was partially attenuated by 45% in presence of Z-VAD-fmk. In fact, the caspase inhibitor only delayed cell death as we observed that after 48 h of Z-VAD-fmk treatment, GFP-P1-expressing cells died as A CK2b subunit-interacting peptide induces p53-dependent cell apoptosis V Martel et al revealed by trypan blue exclusion assay and Hoechst 33 342 staining (data not shown). Mitochondria play a pivotal role in the biochemical events leading to apoptosis (Zamzami et al., 1996) . In particular, caspase-dependent and -independent apoptotic pathways involve the mitochondrial release of proapoptotic proteins, such as Cyt-C and the AIF (Susin et al., 1999; Ferri and Kroemer, 2000) . Indeed, Cyt-C was released to the cytosol in GFP-P1-expressing cells ( Figure 5 ). Similarly, AIF, which is normally retained in the intermembrane mitochondrial space, was confined to mitochondria in GFP-P CT -transfected cells, whereas the protein was translocated to the cytosol and to the nucleus in cells expressing GFP-P1 ( Figure 5 ).
The p53 protein plays a major role in cellular response to various stresses and a concerted set of signalling pathways modify p53 activity by phosphorylation. Radiation-induced phosphorylation of p53 on a CK2 site (Ser 392 in human p53) has been reported (Blaydes and Hupp, 1998) . However, using phospho-p53 (Ser392)-specific antibodies, we could not detect changes in the phosphorylation of this CK2 site in GFP-P1-expressing HCT116 cells (data not shown). An upstream signal in premitochondrial proapoptotic transduction pathway involves phosphorylation of p53 on serine 15 (Vogelstein et al., 2000) . Interestingly, an increased phosphorylation of p53 on serine 15 was detected in GFP-P1-expressing cells. Phosphorylated p53 was confined to the nuclei and was undetectable in GFP-P CTtransfected cells ( Figure 5 ).
The cell cycle inhibitor p21 (WAF/CIP1) is a major transcriptional downstream target of p53 (el-Deiry et al., 1993) . As shown in Figure 5 , a pronounced upregulation of p21 expression could be observed in GFP-P1-expressing cells, whereas this protein was barely detectable in GFP-P CT -transfected cells.
Apoptosis could also be induced in P1-expressing HCT116 colon carcinoma cells (Figure 6 ). P1 expression in these cells was accompanied by ruffling of nuclear membranes and peripheral chromatin condensation. This classical hallmark of apoptosis (Wyllie, 1980) was detectable by staining with the chromatin-specific dye Figure 5 Biological effects of peptide P1. NIH3T3 cells transfected for 24 h with plasmids encoding GFP-P CT or GFP-P1 fusion proteins were fixed and permeabilized followed by staining with antibodies recognizing the p17/p19 fragment of proteolytically activated caspase-3 (casp-3a), Cytochrome C (Cyt.C), AIF, p21 or p53 was phosphorylated on Ser 15 (P-Ser 15 p53) and counterstained with Hoechst 33342. Representative cells are shown. White arrows show the transfected cells.
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Hoechst 33 342 (Andreau et al., 2004) . Importantly, P1-induced apoptosis was dependent on the p53 status because no sign of enhanced nuclear apoptosis was observed in cells in which p53 has been removed by homologuous recombination (Figure 6 ). Similarly, upregulation of p21 and activation of Cyt-C and caspase-3 in response to P1 expression was suppressed in p53 knocked out cells (data not shown).
Discussion
We describe here the selection of a random-sequence aptamer (P1) from a yeast genetic screen that is a potent CK2b-interacting peptide in vitro and in vivo. This aptamer also interacts with CK2b present in cell extracts from different cell lines. A 19-mer synthetic peptide corresponding to its variable region binds directly to CK2b, indicating that this interaction is independent of any bridge protein. The binding affinity of the biot-P1 peptide for CK2b (K D ¼ 0.4 mM) indicates that this concentration is in the same range as that of the effective concentration of anti-Cdk2 (Colas et al., 1996) or anti-E2F aptamers (Fabbrizio et al., 1999) . P1 is rather rich in hydrophobic residues, suggesting that its interaction with CK2b may be hydrophobic. From a deletion study, we demonstrated that the N-terminal aa 1-55 represented the minimal region of CK2b for P1 peptide binding. This region, in the crystal structure of CK2b, is entirely a-helical (a1, a2, a3), extends at the surface of the molecule (Chantalat et al., 1999) and includes the putative destruction box and autophosphorylation sites (Litchfield, 2003) . In agreement with the high-resolution structure of tetrameric CK2 (Niefind et al., 2001) , the interaction of P1 with this region of CK2b neither dissociates the CK2 holoenzyme nor it prevents its formation. Moreover, binding of P1 on A CK2b subunit-interacting peptide induces p53-dependent cell apoptosis V Martel et al CK2b did not change the phosphorylation of Engrailed and CDC25B, two protein substrates that are exclusively targeted by the canonical CK2 holoenzyme (Maizel et al., 2002; Theis-Febvre et al., 2003) . Mounting evidence indicates that CK2 is required for cell viability and plays a critical role in apoptotic signal transduction (Ahmed et al., 2002; Pinna, 2002; Unger et al., 2004) . Accordingly, we have observed that the viability of several mammalian cell types was strongly inhibited upon GFP-P1 expression. In contrast, GFP fused to an irrelevant peptide, which does not bind to CK2b, was without effect, showing that cell apoptosis was dependent on P1 expression. The colocalization of P1 with ectopically expressed CK2b and the protective effect of CK2b overexpression against GFP-P1-induced apoptosis suggests that CK2b may represent the main cellular target for GFP-P1-induced death signalling pathway. However, the inability to fully titrate out GFP-P1 proapoptotic activity by overexpression of HA-CK2b may suggest additional CK2b-independent activity. Several features characteristic of apoptotic cells were detected in peptide GFP-P1-expressing cells. In this respect, CK2 can exert an antiapoptotic role by protecting regulatory proteins from caspase-mediated degradation (Litchfield, 2003) . Conversely, inhibition of CK2 catalytic activity by CK2 inhibitors induces apoptosis in Jurkat cells (Ruzzene et al., 2002) . GFP-P1-induced apoptosis may arise from the activation of caspase signalling as caspase-3 activation was observed in GFP-P1-expressing cells. However, pretreatment of cells by the pancaspase inhibitor Z-VAD-fmk had a partial inhibitory effect on GFP-P1-induced apoptosis, suggesting that caspases were not the sole executioners of this apoptotic death. The mitochondrial Cyt-C release that was detected in GFP-P1-expressing cells indicates that this feature may be a critical event of GFP-P1-induced apoptosis. Moreover, we have observed that the proapoptotic protein AIF, which is confined to mitochondria in healthy cells, was translocated to the nucleus in response to GFP-P1 expression. AIF has been shown to operate independently of caspases, whereas apoptosis that is induced by Cyt-C is dependent on caspase activation (Joza et al., 2001) . Thus, our observations indicate that cell death induced by GFP-P1 may involve classic apoptosis as well as alternative types of programmated cell death (Abraham and Shaham, 2004) .
The reversion of GFP-P1-induced apoptosis observed in TBB-treated cells suggests that this cell death may be at least in part, dependent on CK2-specific cellular substrates whose phosphorylation was inhibited by TBB. This partial reversion also suggests that additionally, a CK2-independent, GFP-P1-induced apoptosis may also exist. Binding of P1 to CK2b may compete for a common binding site on the protein for unknown endogenous ligands that are essential for cell survival. There is mounting evidence that the two CK2 subunits can exist in their free form outside the tetrameric complex (Bibby and Litchfield, 2005; Filhol et al., 2004) . For instance, more than 40 different proteins were shown to interact with CK2b, and importantly, this protein was characterized as a regulatory binding partner of several protein kinases involved in cell signalling (Guerra and Issinger, 1999) . Disruption of CK2b in transgenic mice has revealed the importance of this regulatory protein in the maintenance of cell proliferation and cell viability (Buchou et al., 2003) . Thus, the emerging picture is that CK2b not only exerts a tight control over the catalytic activity of CK2 but may also serve as interaction assembly point for different pathway components (Bibby and Litchfield, 2005) . In this respect, there are examples of cells in which an alteration in a selected protein that signals inappropriately for entry into the cell cycle is detected by the p53 checkpoint. Activation of p53 usually initiates the apoptotic pathway in these cells (Lowe and Sherr, 2003) . This is therefore consistent with the idea that targeting CK2b with P1 may disrupt critical cellular functions of this regulatory protein. Evidence for the recruitment of a p53-dependent apoptosis pathway in response to GFP-P1 expression was suggested by the upregulation of p53 phosphorylated on serine 15 accompanied by p21 transcriptional induction and activation of caspase-3. Phosphorylation of serine residues within the NH2-terminus of p53 was detected in response to initiators such as ultraviolet or ionizing radiation (Rich et al., 2000) . Two different studies identified a role for CK2 in the repair of DNA singlestrand breaks through phosphorylation of the scaffold protein XRCC1 (Loizou et al., 2004; Luo et al., 2004) . However, it is unlikely that DNA damage may be involved in P1-induced apoptosis. On the other hand, p53 phosphorylation on serine 15 was also detected during HIV-induced apoptosis in lymphoid syncycia (Castedo et al., 2001) , corroborating the role of p53 as a major point of integration of DNA damage sensing, but also of other proapoptotic signalling (Vogelstein et al., 2000) . The resistance to P1-induced apoptosis observed in p53-null cells further demonstrates that the apoptogenic effect of P1 requires a functional p53 and that this protein is a necessary intermediate between CK2b and the apoptotic pathway. Future studies will address the involvement of known p53-proapoptotic targets such as Bax, PUMA, NOXA and p53AIP1 in response to GFP-P1-induced apoptosis.
It is noteworthy that most drugs and leads achieve their activity by competing for structurally defined binding site on a protein with endogenous ligands (Hopkins and Groom, 2002) . Interestingly, both the IE protein ICP27 of herpes simplex virus type I and the IE2 protein of herpes virus 6 (HHV-6), which have been implicated in the ethiology of a range of prominent diseases including cancers, are interacting with CK2b, suggesting that some functions of the herpes virus proteins may be regulated by CK2 binding (Wadd et al., 1999; Shimada et al., 2004) . Thus, the significant sequence homology between P1 and the murine cytomegalovirus IE2 protein (Messerle et al., 1991) raises the interesting possibility that this peptide might interact with a domain on CK2b that is targeted by viral proteins. The cytomegalovirus IE2 protein is known to interact with CK2b, inhibits the cell cycle (Wiebusch and Hagemeier, 2001 ) and triggers cell apoptosis (Chiou et al., 2001) . Noteworthy, the interacting domain for the HHV-6 IE2 protein was mapped to the N-terminal region of CK2b extending between aa 1 and 55 (Shimada et al., 2004) , and it is suspected that the tight interaction of this viral protein to CK2b may affect cellular functions specifically involved in cell survival. Thus, by taking a broader perspective of our results, we would suggest that the biological effects of peptide P1 on cell death could mimic those described for some viral proteins. Binding of P1 or viral proteins to the N-terminal domain of CK2b may compete for a common binding site on the protein for unknown endogenous ligands or protein kinase substrates that are essential for cell survival. Indeed, the extreme N-terminal region of CK2b was identified as a binding site for CK2b partners, including topoisomerase II and p53 (reviewed by Bibby and Litchfield, 2005) . Whether transformed cells overexpressing CK2b are more susceptible to GFP-P1-induced cell death remains to be determined. However, the present results encourage further exploration of this possibility. In this respect, our study underscores the functional importance of CK2b in the maintenance of cell viability and the P1 peptide described here provides the first lead that can be exploited to specifically target CK2b and induce apoptosis in cells expressing wild-type p53. Future studies will focus on modelling the interaction between CK2b and P1 in order to identify the fundamental elements for the recognition. This information will make the P1 peptide an interesting guide for the design of small chemical molecules for CK2b-targeted inducers of apoptosis.
Materials and methods
Materials
Biotinylated P1 peptide was synthesized by Neosystem Laboratory (Strasbourg, France). Z-VAD-fmk was purchased from Bachem.
Peptide aptamer screening
The yeast strain EGY48 (Estojak et al., 1995) was MATa, trp1, his3, ura3, LexA op -LEU2 and contained the lexA op -lacZ reporter carried on pSH18-34 plasmid (Golemis and Brent, 1992) . The LexA-CK2b fusion was obtained by cloning the chicken CK2b cDNA in pEG202 vector as described previously (Dagher and Filhol-Cochet, 1997) . The library directed the synthesis of TrxA-fused aptamer encoded by pJM1 plasmid (Colas et al., 1996) was introduced into EGY48 strain that contains the lexA op -lacZ reporter pSH18-34 and the LexA-CK2b bait. Peptide aptamer selection and confirmation steps were performed as described previously (Geyer and Brent, 2000) .
Recombinant proteins production
Production and purification of recombinant proteins MBPCK2b, GFP-CK2a and the different domains of CK2b in fusion with GST were described previously Filhol et al., 2003) .
For GST-P1 recombinant protein, aptamer sequence was excised from pJM1 by EcoRI/NotI and cloned into the EcoRI/ NotI sites of pGEX-4T1 (Amersham Biosciences, Saday, France). Recombinant plasmids encoding GST or GST-P1 were introduced into BL21 E. coli strain. The culture was induced by 0.5 mM of isopropyl thiogalactopyranoside for 2 h at 371C. Bacteria were pelleted and the GST fusion proteins were purified according to the manufacturer's instructions.
GST pull down
Lysates from bacteria expressing GST or GST-P1 were incubated for 1 h at 41C with glutathione beads, washed three times with cold phosphate-buffered saline (PBS) and then incubated with a lysate of Sf9 cells overexpressing CK2b (infection conditions of Sf9 cells are described in Filhol et al., 1991) . After 2 h at 41C, glutathione beads were washed three times with PBS, 1% Triton X-100 and retained material was resolved on 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for immunoblot analysis with an affinity-purified rabbit polyclonal antibody specific for CK2b (b C ).
In vitro binding assays Cell lysates from cultured NIH3T3 or HeLa cells were made in TDG (10 mM Tris (pH 7.5), 1 mM dithiothreitol (DTT), 2% glycerol) containing 2% Triton X-100, 0.5 M NaCl and proteases inhibitors. Samples were centrifugated 15 min at 13 000 g and precleared for 2 h with streptavidin-coated agarose beads (Sigma, Saint Quentin Fallavier, France). Cell lysates were then adjusted at 7 mg/ml in lysis buffer and 1 ml was added to 250 ml of a slurry of streptavidin-coupled agarose beads preincubated in the absence or presence of 350 mg of biot-P1. The interaction assay was carried out overnight at 41C with gentle tumbling. After three washes with TDG, 0.5 M NaCl, 0.1% Triton X-100, retained material was resolved on 12% SDS-PAGE for immunoblot analysis.
Surface plasmon resonance spectroscopy Surface plasmon resonance measurements were performed using a BIAcore 1000 instrument (BIAcore AB, Uppsala, Sweden). The running buffer was HBS (10 mM Hepes (pH 7.3), 0.15 M NaCl, 3 mM ethylenediaminetetraacetic acid (EDTA), 0.005% Tween 20). The carboxymethylated dextran surface of a CM5 sensor chip (BIAcore AB) was activated by injecting a solution of N-hydroxysuccinimide and N-ethyl-N-(dimethylaminopropyl) carbodiimide hydrochloride (coupling solution BIAcore AB). Biot-P1 peptide was diluted at 1 mg/ml in 10 mM acetate buffer, (pH 5.0) and injected over the surface for 6 min at a flow rate of 5 ml/min. The unreacted sites of the sensor chip surface were then capped by injection of 1 M ethanolamine (pH 8.5). Binding of the recombinant proteins MBP or MBP-CK2b was measured at a flow rate of 5 ml/min in HEPES buffered saline (HBS) buffer. The association and dissociation phases were analysed for several concentrations simultaneously, by global fitting to a 1:1 Langmuir binding model using the BIAevaluation 3.2 software (BIAcore AB).
Co-immunoprecipitation of CK2a and CK2b subunits Equal amount (30 mg) of GST or GST-P1 proteins were incubated 1 h at 41C under gentle tumbling either with 5 mg of MBP-CK2b plus 5 mg of GFP-CK2a or with a pre-formed GFP-CK2a/MBP-CK2b complex in PBS, 1% Triton X-100. For immunoprecipitation, each sample was divided in two aliquots and incubated for 1 h at 41C with either a nonimmune antibody or a polyclonal anti-CK2b antibody (b C ) followed by the addition (30 min, 41C) of 10 ml-packed protein G-agarose beads (Sigma), vigorous washing of the pellet, 12% SDS-PAGE and immunoblot detection with an anti-GFP antibody (Roche, Meylan, France).
ELISA assay
Reacti-Bind streptavidin-coated plates (Pierce, Rockford, IL, USA) were coated 1 h at 251C with 100 ml/well of biot-P1 at 20 mg/ml in PBS or with 100 ml of a 3% bovine serum albumin (BSA) solution in PBS as control. After three washes in washing buffer (WB), containing 25 mM Tris (pH 7.5), 150 mM NaCl and 0.05% Tween, wells were blocked 1 h at room temperature with 200 ml of buffer containing 25 mM Tris (pH 7.5), 150 mM NaCl and 3% BSA. Aliquots (100 mg) of GST recombinant proteins fused to different domains of CK2b diluted in 50 mM Tris (pH 7.5) and 0.5 M NaCl were incubated overnight with biot-P1-coated wells. After three washes with WB, a monoclonal anti-GST antibody (Euromedex, Mundolsheim, France) was added into the wells for 1 h followed by three washes with WB and the addition for 30 min of alkalinephosphatase-labelled anti-mouse immunoglobulin G (IgG) diluted in WB. After three washes with WB, 100 ml of phosphatase substrate solution (BioRad, Marnes-la-coquette, France) were added and the plates were read at 415 nm. Assays were run in duplicate and nonspecific binding of GST fusion proteins or GST alone to biot-P1 was subtracted for each recombinant protein.
CK2 activity assays CK2 activity was determined using the synthetic substrate RRREDEESDDEE as described previously (Filhol et al., 1991) . Phosphorylation of Engrailed and Cdc25B proteins was assayed as follows: recombinant Engrailed or Cdc25B proteins (3 mg) were incubated with CK2a (60 ng) in the absence or presence of CK2b (120 ng) and increasing concentrations of P1 peptide. Assays were performed in a final reaction volume of 20 ml containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT, 10 mM MgCl 2 and 0.1 mM [g-32 P]ATP (specific activity 1000-1500 c.p.m./pmol). Reactions were terminated by the addition of Laemmli sample buffer and phosphorylated proteins were analysed by SDS-PAGE and autoradiography.
Transient transfection of cells and immunofluorescence
The p53 WT HCT116 human colorectal adenocarcinoma cell line (HCT116 þ / þ ) and a matched isogenic p53 knockout cell line (HCT116À/À), kindly provided by B Vogelstein (Johns Hopkins University School of Medicine, Baltimore, MD, USA), were maintained in McCoy's medium (Life Technologies Invitrogen, Paisley, UK).
Plasmids encoding GFP-P CT or GFP-P1 were generated by subcloning an insert EcoRI/BamHI from pJM1 aptamercarrying plasmids into the same restriction sites of pEGFP-C2 plasmid (BD Biosciences, Erembodegem, Belgium). Construction of BFP-CAAX and BFP-CK2b-CAAX are described in Martel et al. (2002) . Plasmid encoding HA-CK2b fusion protein was obtained using 5 0 primer (5 0 -TTG AAT TCG CCG CCA CCA TGT ATC CTT ATG ATG TTC CTG ATT ATG CTA TGA GCA GCT CCG AGG AGG TG-3 0 ) and 3 0 primer (5 0 -GAA GAT CTT CAG CGG ATG GTC TTC ACG-3 0 ) and cloned into EcoRI/BgLII sites of pSG5 vector. NIH3T3 and HCT116 cells were cultured on glass coverslips, transfected for 30 h using either Lipofectamine (Invitrogen) or Fugene 6 (Roche) and nuclei were stained by 2 mg/ml Hoechst 33 342 (Sigma) before fluorescence microscopic assessment. For immunofluorescence experiments, cells were fixed with 4% paraformaldehyde for 15 min at 251C and permeabilized for 10 min in PBS 0.5% Triton X-100. After three washes in PBS, cells were stained for the detection of AIF (Chemicon International, Hampshire, UK) or phosphorylated p53 (Ser-15) (Cell Signaling Technology, Ozyme, Saint Quentin, Yvelines, France). Cells were also stained for detection of Cyt-C (monoclonal antibody (mAb) 6H2B4 from Pharmingen, BD Biosciences, Erembodegem, Belgium), cleaved caspase-3 (5A1 rabbit mAb from Cell Signaling Technology). All were detected by a goat anti-mouse or goat anti-rabbit IgGconjugated Cy3 from Molecular Probes and counterstained with the Hoechst 33342 dye (2 mg/ml). Coverslips were mounted with Vectashield medium, and examined using a Zeiss Axiovert 200 M microscope and a 40 Â 1.3 NA Plan Neofluoar objectif.
Flow cytometry
After 48 h of transfection, adherent cells, together with culture medium (which could contained apoptotic cells in suspension), were harvested and washed twice with PBS. For cell cycle analysis, cells were fixed in ice-cold 70% ethanol during 30 min at À201C. After two washes with PBS containing 20 mM EDTA, cell pellet was resuspended in PBS, containing 20 mM EDTA, 20 mg/ml propidium iodide and 100 mg/ml RNase. For Alexa 568-coupled Annexin V (Roche) and TUNEL (Roche) labellings, cells were treated following the manufacturer's instructions. All analysis were performed using a Becton Dickinson FACScan. For each determination, 5000 GFPexpressing cells were analysed.
Apoptosis inhibitors assays NIH3T3 cells were transfected with GFP-P CT or GFP-P1 encoding plasmids, and 5 h later, culture medium was replaced by complete medium containing 50 mM of Z-VAD-fmk or a caspase inhibitor negative control. After 48 h of transfection, cells were collected, labelled with Alexa 568-coupled Annexin V and fluorescence-activated cell sorter (FACS) analysed. NIH3T3 cells were also treated overnight with 1 mM of staurosporin in the presence or absence of Z-VAD-fmk.
